These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9147616

  • 61. Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice.
    Hou WJ, Guan JH, Dong Q, Han YH, Zhang R.
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2902-8. PubMed ID: 24254559
    [Abstract] [Full Text] [Related]

  • 62. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
    Vikhanskaya F, Vignati S, Beccaglia P, Ottoboni C, Russo P, D'Incalci M, Broggini M.
    Exp Cell Res; 1998 May 25; 241(1):96-101. PubMed ID: 9633517
    [Abstract] [Full Text] [Related]

  • 63. Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice.
    Papadopoulou MV, Ji M, Ji X, Bloomer WD, Hollingshead MG.
    Cancer Chemother Pharmacol; 2002 Dec 25; 50(6):501-8. PubMed ID: 12451478
    [Abstract] [Full Text] [Related]

  • 64. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
    Hu L, Hofmann J, Zaloudek C, Ferrara N, Hamilton T, Jaffe RB.
    Am J Pathol; 2002 Nov 25; 161(5):1917-24. PubMed ID: 12414537
    [Abstract] [Full Text] [Related]

  • 65. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
    Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ.
    Cancer Res; 1994 Jul 01; 54(13):3506-10. PubMed ID: 7912167
    [Abstract] [Full Text] [Related]

  • 66. Tumor cell-derived TGF-beta and IL-10 dysregulate paclitaxel-induced macrophage activation.
    Mullins DW, Martins RS, Burger CJ, Elgert KD.
    J Leukoc Biol; 2001 Jan 01; 69(1):129-37. PubMed ID: 11200057
    [Abstract] [Full Text] [Related]

  • 67. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L, Chen W, Wu J, Li H.
    Anticancer Drugs; 2014 Mar 01; 25(3):244-54. PubMed ID: 24275314
    [Abstract] [Full Text] [Related]

  • 68. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
    Chen XP, He SQ, Wang HP, Zhao YZ, Zhang WG.
    World J Gastroenterol; 2003 Nov 01; 9(11):2433-40. PubMed ID: 14606071
    [Abstract] [Full Text] [Related]

  • 69. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 70. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM, Porter DA, Huber SC, Cowan RG.
    Endocrinology; 1998 Dec 15; 139(12):4860-9. PubMed ID: 9832422
    [Abstract] [Full Text] [Related]

  • 71. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
    Ling YH, Yang Y, Tornos C, Singh B, Perez-Soler R.
    Cancer Res; 1998 Aug 15; 58(16):3633-40. PubMed ID: 9721872
    [Abstract] [Full Text] [Related]

  • 72. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
    Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K.
    Exp Biol Med (Maywood); 2009 Oct 15; 234(10):1244-52. PubMed ID: 19657067
    [Abstract] [Full Text] [Related]

  • 73. Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma.
    Gilmore D, Schulz M, Liu R, Zubris KA, Padera RF, Catalano PJ, Grinstaff MW, Colson YL.
    Ann Surg Oncol; 2013 May 15; 20(5):1684-93. PubMed ID: 23128939
    [Abstract] [Full Text] [Related]

  • 74. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK.
    Clin Cancer Res; 2000 Apr 15; 6(4):1498-507. PubMed ID: 10778982
    [Abstract] [Full Text] [Related]

  • 75. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11.
    Gliniak B, Le T.
    Cancer Res; 1999 Dec 15; 59(24):6153-8. PubMed ID: 10626806
    [Abstract] [Full Text] [Related]

  • 76. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB.
    Cancer Res; 2002 Feb 15; 62(4):1087-92. PubMed ID: 11861387
    [Abstract] [Full Text] [Related]

  • 77. The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.
    Garofalo A, Naumova E, Manenti L, Ghilardi C, Ghisleni G, Caniatti M, Colombo T, Cherrington JM, Scanziani E, Nicoletti MI, Giavazzi R.
    Clin Cancer Res; 2003 Aug 15; 9(9):3476-85. PubMed ID: 12960140
    [Abstract] [Full Text] [Related]

  • 78. Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Siim BG, Lee AE, Shalal-Zwain S, Pruijn FB, McKeage MJ, Wilson WR.
    Cancer Chemother Pharmacol; 2003 Jan 15; 51(1):43-52. PubMed ID: 12497205
    [Abstract] [Full Text] [Related]

  • 79. [Effects of RelA antisense oligonucleotide on apoptosis of ovarian cancer cells COC1].
    Wang C, Hu F, Lu Y, Wang S, Ma D.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Apr 15; 37(4):202-4. PubMed ID: 12133409
    [Abstract] [Full Text] [Related]

  • 80. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
    Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, Kikkawa F.
    Int J Oncol; 2007 Aug 15; 31(2):277-83. PubMed ID: 17611683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.